Rhoen-Klinikum AG
General ticker "RHKJF" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $989.0M (TTM average)
Rhoen-Klinikum AG follows the US Stock Market performance with the rate: 7.3%.
Estimated limits based on current volatility of 0.0%: low 15.30$, high 15.30$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-05, amount 0.11$ (Y0.72%)
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.85$, 16.24$]
- 2025-12-31 to 2026-12-31 estimated range: [11.62$, 17.32$]
Financial Metrics affecting the RHKJF estimates:
- Positive: with PPE of 18.7 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 3.02
- Positive: Operating cash flow per share per price, % of 15.58 > 13.24
- Negative: Industry operating cash flow per share per price (median), % of 3.25 <= 5.52
- Negative: Return on assets ratio (scaled to [-100,100]) of 2.38 <= 6.04
- Negative: Industry operating profit margin (median), % of -3.16 <= 2.97
- Negative: 0 < Inventory ratio change, % of 0.59
- Positive: -14.38 < Investing cash flow per share per price, % of -6.15
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term RHKJF quotes
Long-term RHKJF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €1,446.09MM | €1,734.72MM | €1,595.62MM |
| Operating Expenses | €1,409.97MM | €1,694.33MM | €1,547.47MM |
| Operating Income | €36.11MM | €40.40MM | €48.15MM |
| Non-Operating Income | €-2.48MM | €7.33MM | €8.05MM |
| Interest Expense | €4.10MM | €3.70MM | €3.40MM |
| Income(Loss) | €33.63MM | €47.73MM | €56.20MM |
| Taxes | €6.69MM | €7.56MM | €11.00MM |
| Profit(Loss)* | €25.14MM | €38.71MM | €43.35MM |
| Stockholders Equity | €1,223.80MM | €1,252.04MM | €1,295.93MM |
| Inventory | €33.32MM | €34.21MM | €37.46MM |
| Assets | €1,704.94MM | €1,770.52MM | €1,856.48MM |
| Operating Cash Flow | €60.30MM | €109.00MM | €127.60MM |
| Capital expenditure | €58.20MM | €62.80MM | €70.40MM |
| Investing Cash Flow | €-105.20MM | €40.90MM | €-50.40MM |
| Financing Cash Flow | €-4.10MM | €-21.20MM | €-3.30MM |
| Earnings Per Share** | €0.38 | €0.58 | €0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.